CTLA4 and hypophysitis: Hypophysitis is a recognized irAE-particularly with CTLA-4 inhibitors-but this case is notable for occurring in an elderly patient receiving combination therapy and presenting with nonspecific symptoms that mimicked cancer-related fatigue and treatment side effects.